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Abstract
Milk from different species has been exploited for the isolation of various functional ingredients for decades.
Irrespective of the source, milk is considered as a complete food, as it provides essential nutrients required by the
human body. Proteins and their fractions are valuable sources of bioactive peptides that might exert a health
beneficial role in the human body such as immune-modulation, antioxidant activity, ACE-inhibitory activity, antineoplastic, anti-microbial, etc. In milk, bioactive peptides may either be present in their natural form or released
from their parental proteins due to enzymatic action. The increasing interest in bioactive peptides among
researchers has lately augmented the exploration of minor dairy species such as sheep, goat, camel, mithun, mare,
and donkey. Alternative to cow, milk from minor dairy species have also been proven to be healthier from infancy
to older age owing to their higher digestibility and other nutritive components. Therefore, realizing the significance
of milk from such species and incentivized interest towards the derivatization of bioactive peptides, the present
review highlights the significant research achievements on bioactive peptides from milk and milk products of minor
dairy species.
Keywords: Milk protein, Bioactive peptides, Camel, Goat, Sheep, Donkey

Introduction
Milk occupies an essential component of the human diet
globally. Reports suggest that dairy products are being
consumed by more than 6 billion people across the
world (FAO 2013). Various species have been utilized
for the production of milk. The majority of milk comes
from dairy cows and buffaloes followed by other minor
dairy species including goats, sheep, camels, yak, mare,
donkey, Mithun, etc. Each species has its significance according to its predominance in a particular region or
country. However, cows contribute 85% of the world’s
total milk production while other minor dairy species
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such as buffalo, goat, sheep, and camel contribute 11,
2.3, 1.4, and 0.2%, respectively (Gerosa and Skoet 2012).
Milk, a lacteal secretion from healthy milch animal,
contains numerous nutrients including proteins, carbohydrates, fats, minerals, and vitamins, and thus possess a
wide range of nutritional and functional properties.
Although the milk composition of any species is based
on the requirement of the neonate (Gobbetti et al. 2007;
McGrath et al. 2016; Park 2009a), it has also been explored for additional health benefits for infants, children,
and adults of mammalian species, beyond their basic nutritional role (Park 2009b) Among various nutrients,
protein (3.2 g/100 mL) is one of the most functionally diverse nutrients, and its level and functional properties
differ among different species (Regester et al. 1997).
Functionally, milk proteins provide a characteristic
structure, solubility, water binding, viscosity, and heat
stabilization properties to dairy products (Augustin and
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Udabage 2007; Korhonen and Pihlanto-Leppala 2004).
From the nutritional point of view, the milk protein is
enriched with bioactive substances. Milk protein and
their fractions are valuable sources of bioactive peptides
with various biological activities such as, antithrombotic,
antimicrobial, antioxidative, antihypertensive, immunomodulatory, and sometimes they possess multifunctional
activity (Park and Nam 2015). The importance of milk
from minor dairy species is growing worldwide. Reports
indicate that the world production of non-bovine milk
was increased by 165% from 1983 to 2013 while bovine
milk production had shown an increase by only 41%
(Nuñez and de Renobales 2016). Milk from these minor
species not only plays a vital role for producers but also
for consumers worldwide. Intense research has been
carried out on bioactive peptides, their identification,
characterization, and utilization in functional foods,
from cow’s milk and milk products. However, since the
last two decades, few studies have been focused on the
exploration of proteins and their fractions from minor
dairy species, particularly for the presence of bioactive
peptides. The majority of the work is focused on the release of peptides during in vivo or in vitro digestion of
proteins (Giacometti and Buretić-Tomljanović 2017).
Hence, there still exists untapped and unexplored knowledge in milk and milk products from minor dairy species mainly in the area of bioactive peptides. To the best
of our knowledge, very little and scattered information is
available in the literature regarding the bioactive peptides from minor dairy species. Therefore, this review focuses on the gross composition of milk, bioactive
peptides derived from milk and milk products of minor
dairy species, and their physiological roles in the human
body.
Gross composition of milk from minor dairy species

The main intent of milk production, for all terrestrial
mammals, is to suffice the nutritional requirements of
the neonates. Therefore, milk of all species broadly constitutes the same nutrients, such as proteins, carbohydrates, fat, minerals and water. In addition to these
macronutrients, milk also constitutes several biologically
active compounds such as growth factors, immunoglobulins, antimicrobial proteins, antibacterial peptides, and
hormones, to help the neonates with various physiological functions (Alichanidis et al. 2016). However,
among various species, the milk composition, both
major and minor constituents, differs depending on nutritional, genetic, and environmental factors. The milk
composition also determines its appropriateness as a raw
material for various dairy products, its nutritive value, as
well as its organoleptic and physicochemical characteristics (Alichanidis et al. 2016). Furthermore, it has also
been observed that ruminant and non-ruminant milk is

Page 2 of 21

generally distinctive based on their composition. For instance, ruminant milk is characterized by a high total
solid content with a higher fat, protein, and ash content
(Medhammar et al. 2012; Potočnik et al. 2011). On the
other hand, non-ruminant milk such as those of mare,
donkey, and humans, constitute more lactose content
(Guo et al. 2007; Martini et al. 2014) Nowadays, milk is
regarded as one of the most exclusively complete foods
which have become a fundamental part of the human
diet. Table 1 provides the gross composition of milk
across various minor dairy species covered under this
review.
Gross composition of protein fraction in milk of minor
dairy species

Milk proteins can be broadly divided into three major
fractions, namely, casein, whey protein, and non-protein
nitrogenous fraction. Milk casein is characterized as the
protein that precipitates at isoelectric pH 4.6, whereas
whey protein fraction comprises of all the other noncasein proteins which remain soluble. Milk also consists
of small amounts of nitrogenous compounds, which are
not part of any protein, and are known as non-protein
nitrogen (NPN). This includes free amino acids, peptides, creatine, urea, ammonia, uric acid, orotic acid
(Michaelidou 2008). Casein is heterogeneous and it contains four major forms: αs1-casein, αs2-casein, β-casein,
and κ-casein (Eigel et al. 1984). Ruminant milk consists
of casein as the major protein fraction, whereas, in nonruminant milk, whey protein content is characteristically
higher than casein fraction. The casein to whey protein
ratio largely varies among different species of mammals.
For instance, in mare milk, the ratio is 50:50, human
milk is 40:60, whereas, in sheep, goats, cows, and buffaloes, the ratio is around 80:20. Moreover, the different
forms of caseins are found in different proportions in
milk from different species. For example, β-casein is the
dominant form in both goat and camel milk (Al Haj and
Al Kanhal 2010; Kappeler et al. 2003; Moatsou et al.
2006), whereas β-casein and αs—casein are the main
forms in mare milk (Malacarne et al. 2002).
Whey proteins can be further classified as α-lactalbumin,
β-lactoglobulin, immunoglobulins, blood serum albumin
Table 1 Gross composition (%) from milk of minor dairy species
Species

Total solids

Protein

Lactose

Fat

Ash

Camel

14.4

3.7

5.1

4.9

0.7

Goat

12.1

3.1

4.6

3.5

0.8

Sheep

16.3

5.5

4.6

5.3

0.9

Yak

16.8

5.2

4.6

7.0

–

Donkey

10.2

1.7

6.9

1.2

0.4

Mare

11.0

2.7

6.1

1.6

0.5

The table is adapted and modified from (Park and Haenlein 2006)
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(BSA), and miscellaneous minor proteins. α-lactalbumin is
the most common constituent of whey protein which is
found in the milk of all mammals and plays a major role in
the synthesis of the milk sugar, lactose. β-lactoglobulin is
the major whey protein found in the milk, however, it is
not present in camel and human milk. β-lactoglobulin accounts for about 50% of the total whey proteins in ruminant milk and about 35% in donkey and mare milk
(Alichanidis et al. 2016). The NPN content in the milk of
mammals is highly variable and it is influenced by breed,
herd, lactation, seasons, and feeding practices. For instance,
the NPN content in mare milk is around 10–15% of the
total milk nitrogen content, in cow milk, it is 5%, whereas
in human milk it is about 25%. Ruminant milk has about
3–5% NPN, and, sheep and goat have higher content than
cow milk. The most dominant fraction in the NPN is urea,
which can account for about 50% of the total nitrogen content of NPN. The next most abundant component is the
free amino acids, which accounts for about 16% in sheep
milk, 10–20% in cow milk, and about 9–10.5% in goat milk.
Taurine, citrulline, and ornithine, which are not a part of
protein-bound amino acids, are also found in certain milk.
Taurine is a growth modulator and membrane stabilizer
and plays a significant role in the formation of bile acids.
Taurine is the most abundant amino acid in goat milk
followed by human milk. Table 2 gives a detailed comparative view of the protein composition profile of milk from
different mammals.
Bioactive peptides derived from milk of minor dairy
species
Camel milk

Camel milk has a special significance in human nutrition, particularly in hot and arid countries. The global
production of camel milk is estimated to be 5.3 million
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tons, with Somalia being the major producer (Food and
Agriculture Organization of the United Nations n.d.).
Camel milk consists of four major types of caseins,
namely, αs1-casein, αs2-casein, β-casein, and κ-casein.
Among these, β-casein content was the highest (65%),
followed by αs1-casein (22%) and κ-casein (3%) (Farrell
et al. 2004). Furthermore, camel milk has been reported
to be more susceptible to digestion with chymotrypsin,
suggesting the fact that a large number of potential
bioactive peptides could be generated from camel
milk (Salami et al. 2008). The presence of such bioactive peptides from camel milk has been listed as
follows:
Antioxidant peptides Hydrolysis of camel milk using
pepsin-pancreatin enzymes yielded peptides with antioxidant and anti-cytotoxic activity (Homayouni-Tabrizi
et al. 2017). Concentration and purification of the peptides were achieved through ultrafiltration and reverse
phase liquid chromatography, respectively. Three peptides with sequences LEEQQQTEDEQQDQL (MW:
1860.85 Da, LL-15), YLEELHRLNAGY (MW: 1477.63
Da, YY-11), and RGLHPVPQ (MW: 903.04 Da, RQ-8)
were obtained and exhibited high free radical scavenging
activity and increased expression of dismutase and catalase genes in cell line. Ibrahim et al. (2018) fractionated
camel milk proteins and hydrolyzed them separately
using pepsin. Results revealed that antioxidant peptides
with molecular weights between 913 to 2351 Da were
derived from α-casein and lactoferrin, respectively, thus
suggesting that both casein and whey proteins from
camel milk have the potential for being utilized as an ingredient in nutraceuticals or functional foods. Kumar
et al. (2016b) used commercial proteases namely papain,
Alcalase and chymotrypsin to hydrolyze the casein

Table 2 Comparative protein composition profile from milk of minor dairy species (concentration range)
Protein Fraction

Camel

Goat

Sheep

Yak

Donkey

Mare

Total casein (g/kg)

22–48

23–38

41–66

21–40

6–10

8–14

αs1-Casein (% total)

21

4.5–34

7–40

13–32

–

17–47

αs2-Casein (% total)

9

9–25

12–23

9–18

–

2

β-Casein (% total)

65

34–64

34–62

37–51

–

46–79

κ-Casein (% total)

3–5

10–19

7–23

12–21

–

2–8

γ-Casein (% total)

–

5–6

–

–

–

–

Total whey proteins (g/kg)

6–10

3–12

8–16

11

5–9

7–10

α-Lactalbumin (% total WP)

45–53

17–50

13–45

7–20

23–33

17–42

β-Lactoglobulin (% total WP)

–

34–77

28–72

50–86

30–57

17–50

Serum albumin (% total WP)

30–41

5–22

6

7–15

6–7

3–5

Immunoglobulins (g/kg)

0.55–0.8

0.15–0.5

0.5–0.7

0.1–0.4

1.3

0.4–2.5

Lactoferrin (g/kg)

0.2–0.9

0.02–0.3

0.7–0.9

0.2–0.7

0.3

0.6–1.3

NPN (% total N)

6–11

7–12

6–9

6

11–25

10–15

The table is adapted and modified from (Alichanidis et al. 2016)
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fraction of camel milk protein. It was found that the hydrolysate obtained by chymotrypsin had a higher antioxidant activity, while Alcalase and chymotrypsin both
yielded peptides with comparable antimicrobial activity.
They concluded that the whole milk protein hydrolysate
could be more beneficial when used as a nutraceutical or
functional food ingredient in comparison to hydrolysates
of milk protein fractions. Jrad et al. (2014) had studied
the antioxidant properties of camel milk casein hydrolysate using 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) radical cation and concluded that
antioxidant activity of camel milk casein was much more
efficient after digestion with pepsin and pancreatic enzymes. On similar lines, Kumar et al. (2016a) investigated the antioxidant activity of casein hydrolysate after
hydrolysis by Alcalase and papain. They found that both
the hydrolysates obtained exhibited a significant increase
in 2,2-diphenyl-1-picrylhydrazyl (DPPH), Ferric Reducing Antioxidant Power (FRAP), and ABTS, with an increase in the duration of hydrolysis and degree of
hydrolysis. Three novel antioxidant peptides have been
isolated from Bactrians camel milk hydrolysate by Wali
et al. (2020). All purified and sequenced peptides: RLDG
QGRPRVWLGR (TFI-b1), MW: 1665.94; TPDNIDIW
LGGIAEPQVKR (TFI-b2), MW: 2122.13,andVAYSDDGENWTEYRDQGAVEGK (TFI-b3), MW: 2489.09 exhibited very high antioxidant activity as free radical
scavengers.

the digestion with pepsin enhanced the ACE-inhibitory
activity of the whole as well as β-casein. Therefore, camel
milk was suggested to release innate peptides with antihypertensive properties. Mimicking the in vitro gastrointestinal digestion model for digestion of camel milk proteins
(whey and casein), it was found that a higher ACE inhibitory activity was achieved following digestion with pepsin
(Jrad et al. 2014). Moreover, camel colostrum also exhibited a higher ACE-inhibitory activity following digestion.
The study identified 180 peptides with biological activities,
out of which 25 peptides were known to be associated
with ACE-inhibitory activity. Shuangquan et al. (2008)
had also studied the ACE inhibitory activity of fermented
skim camel milk. Fermentation of skim camel milk was
achieved by culturing with L. helveticus130 B4. Peptide sequences exhibiting the strongest antihypertensive activity
were derived from κ-casein and it was also demonstrated
that inhibitory activity was quite stable after treatment at
100 °C for 20 min. Rahimi et al. (2016) had used proteinase K for the evaluation of ACE inhibitory activity of
camel milk casein hydrolysate and results recommended
the use of whole camel casein as a substrate for the production of peptides with antihypertensive properties.
Soleymanzadeh et al. (2019) had identified a novel ACE
inhibitory peptide from fermented camel milk (Leuconostoc lactis). Less than 3 kDa ultra filtered fraction with
biologically active peptide (MVPYPQR) exhibited ACEinhibitory activity with IC50 value of 1.61 ± 0.18 mg/mL.

ACE inhibitory peptides Higher proline content in the
structure of casein fraction of camel milk is reported to be
a contributory factor for better ACE inhibitory and antioxidant activity of hydrolysates obtained from camel milk
as compared to the milk from other species (Moslehishad
et al. 2013). ACE inhibitory activity of camel milk hydrolysate obtained by in vitro gastrointestinal digestion was
studied by Tagliazucchi et al. (2016). They studied the different fractions and found that the strongest ACE inhibitory activity was exhibited by the post-pancreatic < 3 kDa
fraction. Sequencing of these fractions yielded 17 peptides
known to possess ACE inhibitory activity. In another
study by Alhaj (2016), peptides possessing ACE inhibitory
activity were identified from fermented camel milk of
dromedary species. Camel milk was fermented with two
potent bacterial cultures namely, L. helveticus and L. acidophilus. HPLC-MALDI-TOF analysis showed the presence of ten potent peptides exhibiting ACE-inhibitory
activity. Camel milk fermented with L. heveticus yielded
stronger ACE-inhibitory activity than other strains (L.
acidophilus). Results of this study also revealed that these
peptides were stable up to 15 days of storage. Camel milk
protein fractions, namely β-casein and whole casein, were
also studied by Salami et al. (2010), and they evaluated the
biological activity of these fractions. Results showed that

Anti-diabetic and Anti-obesity peptides Novel antidiabetic and anti-obesity peptides (KDLWDDFKGL,
MPSKPPLL) were obtained in the hydrolysates of
camel milk protein in a study by Mudgil et al. (2018).
Nongonierma et al. (2017) identified anti-diabetic peptides with dipeptidyl peptidase 4 (DPP-IV) inhibitory
activity, in camel milk protein hydrolysates. Results revealed the presence of potential and novel DPP-IV inhibitory peptides (Leu-Pro-Val-Pro-Gln and Trp-Lys)
which were reported to be absent in bovine milk hydrolysates. This indicated the unexplored potential of
camel milk as a substrate for diabetes management.
Also, Nongonierma et al. (2018) identified nine novel
peptides possessing DPP-IV inhibitory activity (FLQY,
FQLGASPY, ILDKEGIDY, ILELA, LLQLEAIR, LPVP,
LQALHQGQIV, MPVQA, and SPVVPF) upon the hydrolysis of camel milk protein with trypsin. Thus,
camel milk was reported to be an important commodity having a role in glycemia regulation. Cholesterol
esterase has been reported to be associated with the
development of obesity and other related complications.
Thus, in an interesting study conducted by Mudgil et al.
(2019), novel peptides were isolated from camel milk protein hydrolysate and then evaluated for their inhibition of
cholesterol esterase. Results revealed that hydrolysate
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obtained by the digestion with papain exhibited the highest degree of hydrolysis. Peptide identification showed
three peptides with sequences KFQWGY, SQDWSFY,
and YWYPPQ, exhibiting high affinity towards the binding site of cholesterol esterase.
Antimicrobial peptides In a study by Algboory and
Muhialdin (2018), protein hydrolysates found in fermented camel milk produced using Lactobacillus plantarum,
exhibited antimicrobial activity against Staphylococcus
sp., Shigella, and E. coli. One of the fractions, out of the
14 isolated, yielded 32 low molecular weight peptides
and exhibited the strongest antimicrobial activity. This
study suggested the utilization of L. plantarum as a suitable starter culture for the production of antimicrobial
peptides in camel milk-based functional products. Jrad
et al. (2014) investigated the antimicrobial properties of
camel colostrum as well as camel milk proteins and
demonstrated that colostrum and milk both had an inhibitory effect on the growth of E.coli and L. innocua.
They also showed that the antimicrobial effect was significant even before the digestion of the sample, however, it became pronounced after the samples were
subjected to gastric and intestinal proteolytic enzymes.
Abu-qatouseh (2019) derived immune proteins and peptides from camel milk and evaluated their efficacy
against Propionibacterium acnes. It was shown that peptidoglycan recognition proteins exhibited the strongest
antimicrobial activity as compared to lactoferrin. Thus,
camel milk was suggested to be utilized for the treatment of Acne vulgaris.
Goat milk

Goat milk has been extensively studied and characterized for their bioactive peptides. They also contain the
four main fractions of caseins (αs1-casein, αs2-casein, βcasein, and κ-casein), however, goat casein has been
found to undergo a broad range of post-translational
modifications leading to the production of a wide variety
of the casein molecule (Marletta et al. 2007). Goat milk
whey proteins primarily consist of α-lactalbumin and βlactoglobulin, the latter being significantly higher in concentration than cow’s milk (Moatsou et al. 2005). Various bioactive peptides have been reported to be
produced from goat milk and milk products in the past
decades. Some of those beneficial properties are reported
here as follows:
Antioxidant peptides Fermented goat milk has shown
the presence of antioxidant peptides more often. In this
regard, Lactobacillus casei L61 was used to ferment the
goat milk and the milk was further subjected to isolation
and purification of antioxidant peptides (Shu et al.
2018). They proved that these antioxidant peptides were
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quite stable during simulated in vitro digestibility experiment. Commercial proteases namely, subtilisin and trypsin, were used to produce goat milk microfiltration
hydrolysate (De Gobba et al. 2014). It was found that the
retentate generated with subtilisin hydrolysis, showed
the highest radical scavenging activity, whereas, the permeate had a high iron chelation capacity and formed a
large number of secondary lipid oxidation products. The
role of non-protein compounds in permeate was
highlighted more than the antioxidant activity related
peptides. Similarly, antioxidant peptides were identified
in goat milk protein fractions by Ahmed et al. (2015).
Goat milk proteins were fractionated into casein and
whey, which were further digested using pepsin. Peptides
generated showed potent DPPH and superoxide quenching activity. MALDI-TOF-MS was further used to identify
these peptides and it was found that β-casein and βlactoglobulin were the major contributors to these antioxidant bioactive peptides. In a study by Li et al. (2013), antioxidant peptides were purified and identified from casein
protein fraction of goat milk. Neutral and alkaline proteases were used to produce goat milk casein hydrolysate.
They found a significant increase in free radical scavenging and iron chelation capacities with goat milk protein
hydrolysate which was attributed to five novel oligopeptides, namely Val-Tyr-Pro-Phe, Phe-Gly-Gly-Met-Ala-His,
Phe-Pro-Tyr-Cys-Ala-Pro, Tyr-Val-Pro-Glu-Pro-Phe, and
Tyr-Pro-Pro-Tyr-Glu-Thr-Tyr. Antioxidant activity of
these peptides were 3.60 to 3.80 times higher than the
goat milk casein.
ACE inhibitory peptides ACE inhibitory peptides have
an immense role in lowering blood pressure or to combat hypertension. Commercial proteases have been studied for ACE inhibitory peptide production from goat
milk by Bao et al. (2016). Alcalase was found to be the
best enzyme for the production of ACE-inhibitory peptides with 95.31% activity. In another study by Geerlings
et al. (2006), subtilisin and Alcalase were used to identify
and characterize ACE inhibitory peptides from goat
milk. They isolated three novel ACE inhibitory peptides
namely, TGPIPN, SLPQ, and SQPK, with inhibitory concentrations of 316, 330 and 354 μmol/L, respectively. In
the same study, the efficacy of the goat milk protein hydrolysate was evaluated using in vivo models and it was
found that the long-term administration of goat milk
protein hydrolysate reduced the occurrence of hypertension, cardiac and renal hypertrophy, and renal dysfunction. Espejo-Carpio et al. (2014) produced ACE inhibitory
peptides from ultra-filtered goat milk protein hydrolysates
(casein fractions). Treatment of ultra-filtered goat milk casein with subtilisin and trypsin exhibited relatively higher
ACE inhibitory activity. Besides commercial proteases,
purified proteinase has also been studied for its efficacy in
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the production of peptides. One such study employed
partially purified proteinases of Lactobacillus helveticus PR4 and the hydrolysate was subjected to reversed phase fast protein liquid chromatography for
peptide fractionation (Minervini et al. 2003). Fractions
with the highest ACE inhibitory activity (β-CN f58–
65 and αS2-CN f182–187) were sequenced by mass
spectroscopy. Corresponding sequences obtained were
LVYPFPGP and TVDQHQ with monoisotopic mass
of 888.47 Da and 727.33 Da, respectively.
Bacterial cultures have also been used for the production of ACE inhibitory peptides. Chen et al. (2018) used
Lactobacillus plantarum 69 to ferment goat milk and
evaluate its potential to generate ACE inhibitory peptides. The generated hydrolysate exhibited 88.91% ACE
inhibitory activity; however, when it was further purified
by ultrafiltration and RP-HPLC, it showed an ACE inhibitory activity of 91.62%. Another study conducted by
Shu et al. (2017) utilized Lactobacillus bulgaricusLB6 for
the fermentation of goat milk to increase antihypertensive activity. Results showed an increase in ACE inhibitory activity by 10% (from 75% to around 84.6%).
Ibrahim et al. (2017) evaluated the presence of ACE inhibitory peptides separately in casein and whey fractions
of goat milk. They found that pepsin generated hydrolysates of whey and casein demonstrated significantly
higher ACE inhibitory activities as compared to the undigested proteins. Furthermore, they identified three potent ACE inhibitory peptides namely, PEQSLACQCL
from β-lactoglobulin (residues 113–122), QSLVYP
FTGPI from β-casein (residues 56–66), and ARHPHPHL
SFM from κ-casein (residues 96–106), which exhibited
significantly higher ACE inhibitory activity than a commercial antihypertensive drug, captopril. In another
study conducted by Aslam et al. (2018), goat milk proteins were fermented with Lactobacillus helveticus -cicc
22,171 and further hydrolyzed to elucidate the structure
and amino acid sequences with mass spectrometry. The
results revealed that the peptides, VLPVPQKAVPQ and
VLPVPQKVVPQ containing PVP and VVP, exhibited
the highest ACE inhibitory activity owing to their higher
concentration of hydrophobic and aromatic amino acids.

QSVL, VMFPPQSVL, and INNQFLPYPY, after treating
the goat milk casein with trypsin and chymotrypsin. They
have used two-dimensional silica-thin layer chromatography technique for their isolation and identification.

Anti-diabetic peptides Bioactive peptides involved in
reducing the blood glucose levels were isolated from
goat milk hydrolysate using liquid chromatography-mass
spectrometry technique by Gong et al. (2020). Identified
bioactive peptides were SDIPNPIGSE (αS1-casein, f195–
204), NPWDQVKR (αS2-casein, f123–130), SLSSSEES
ITH (β-casein, f30–40), and QEPVLGPVRGPFP (β-casein, f207–219). These peptides improved insulin resistance in HepG2 cells when treated with high glucose.
Zhang et al. (2015) isolated and identified novel DPP-IV
inhibitory peptides namely, MHQPPQPL, SPTVMFPP

Sheep milk consists of high protein content (around
5.8% on average), however, this varies among different
breeds of sheep, usually influenced by genetic and environmental factors (Recio et al. 2009). Sheep milk protein
is characterized by 76–83% of total casein and 17–24%
of total whey proteins (Moatsou et al. 2005). The casein
protein is further relatively distributed as 12–16.4% of
αs2-casein, 33.9–39.9% of αs1-casein, 37–42.3% of βcasein, and 9.1–10.8% of κ-casein (Moatsou et al. 2004).
Sheep milk protein hydrolysates have been shown to
possess multiple health beneficial factors as follows:

Antimicrobial peptides The commercial protease,
Alcalase, was used to hydrolyze whey protein fraction of
goat milk (Osman et al. 2016). Fractions with the highest
degree of hydrolysis were fractionated further and evaluated for their antibacterial activity by disc diffusion
method. Fractions eluted by size exclusion chromatography showed antibacterial activity against E.coli with a
minimum inhibitory concentration (MIC) of 0.09 mg/
mL and against B.cereus (MIC: 0.03 mg/mL). The study
concluded with the potential of goat milk whey hydrolysate to control undesirable bacteria in food products.
Fungal proteases, from Aspergillus oryzae and Aspergillus
flavipes, have also been used to hydrolyze goat milk,
which was further evaluated for their potential role in
antimicrobial activity (Zanutto-Elgui et al. 2019). Results
revealed that the generated peptides exhibited antimicrobial activity against all tested bacteria and fungi.
Goat milk whey fraction has also been evaluated for its
antifungal and antimycotoxigenic activity on Penicilliumspp (Luz et al. 2020). Twenty seven peptides were
identified from α-lactalbumin, β-lactoglobulin, κ-casein
and lactoferrin, which exhibited fungal growth inhibition
and Minimum Inhibitory Concentration (MIC) of 3.9–
62.5 g hydrolysate/L. In another study by Lestari and
Suyata (2019), goat milk from Etawa breed was hydrolysed with crude extract of bromelain enzyme (from
pineapple). The hydrolysate was tested for its antibacterial activity (against E. coli and S. aureus) and the results
demonstrated significantly higher antibacterial activity
compared to the non-digested control. Similarly,
Esmaeilpour et al. (2016) used trypsin and ficin enzymes
to evaluate the efficacy of goat milk casein hydrolysate and
reported that one of the fractions (F14) possessed a very
high antibacterial activity against E.coli and B.cereus.
Sheep
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Antioxidant peptides Hydrolysis of sheep milk sodium
caseinate with Bacillus sp. P7 protease generated peptides with an antioxidant activity which was higher than
the intact protein (Corrêa et al. 2011). Sequential hydrolysis of the sheep casein protein with pepsin, trypsin,
and chymotrypsin produced hydrolysates with high antioxidant activity, and this effect was more pronounced
with κ –casein. The most potent peptide found in the
κ–casein hydrolysate was HPHPHLSF, among eleven
other peptides identified, showing the antioxidant activity.
The isolated peptide HPHPHLSF demonstrated lipid peroxidation inhibition activity similar to the synthetic antioxidant Butylated hydroxytoluene (BHT). The strong
antioxidant activity of the peptide was mainly attributed
to the presence of high histidine and leucine content in
the peptide sequence, which is known for its oxidation inhibition properties. Besides, even proline has been known
for its antioxidant properties. Thus, the peptide HPHPHL
SF could potentially be used as a natural antioxidant replacing the synthetic ones (Gómez-Ruiz et al. 2008).
ACE inhibitory peptides ACE inhibitory peptides were
generated from sheep sodium caseinate hydrolysis via
Bacillus sp. P7 protease. However, 2 h hydrolysis produced the most active peptides while an increase in the
hydrolysis time decreased the ACE inhibitory activity
(Corrêa et al. 2011). Sheep casein hydrolyzed by Lactobacillus helveticusPR4 proteinase generated ACE inhibitory peptides derived from αs2-casein (residues 182–185)
and αs1-casein (residues 1–6) (Minervini et al. 2003).
Trypsin hydrolysis of sheep β-lactoglobulin (both A and
B variants mixture) generated ACE inhibitory peptides
from the N-terminal of the protein. Among those peptides, the more hydrophilic ones were shown to possess
higher ACE inhibitory activity (Recio et al. 2009).
Antimicrobial peptides Bacillus sp. P7 derived protease
hydrolysis of sheep caseinate produced hydrolysates
which demonstrated antimicrobial activities against Corynebacterium fimi, Bacillus cereus, Aspergillus fumigatus,
and Penicillium expansum (Corrêa et al. 2011). Peptic
hydrolysis of the αs2-casein generated four antibacterial
peptides from the casein protein corresponding to the
amino acid residues 165–181 (LKKISQYYQKFAWPQY
L),165–170 (LKKISQ), 203–208 (PYVRYL), and 184–
208 (VDQHQKAMKPWTQPKTNAIPYVRYL). These
peptides were shown to be effective against various
Gram-positive and Gram-negative bacteria. Among the
four peptides, the most potent one was derived from
amino acids 165–180 (López-Expósito et al. 2006). Sheep
α-lactalbumin and β-lactoglobulin hydrolysis with pepsin
generated hydrolysates capable of exhibiting dosedependent antibacterial activity against Bacillus subtilis,
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Escherichia coli, and Staphylococcus aureus (Elzahar et
al. 2004).
Antithrombic peptides Sheep casein glycomacropeptide (CMP) has been demonstrated to possess antiplatelet aggregation properties and this activity was further
shown to increase with trypsin hydrolysis. Trypsin hydrolysis of sheep CMP released two peptides derived from
κ-casein (amino acids 163–171 and 165–171) which had
high antithrombotic activities (Qian et al. 1995).
Yak

Yak milk consists of high protein content (46.2–58.4 g/
L) out of which casein constitutes almost about 40.2 g/L
on an average. It is also rich in milk fat (6.7%) and nonfat solids (11%). Yak milk products are a major ingredient in the Mongolian indigenous diet (Ochirkhuyag et
al. 1997).
In a study by Jiang et al. (2007), yak milk casein was
hydrolyzed by six different protease enzymes. The hydrolysates with the highest ACE inhibitory activity were
obtained from the hydrolysis with Neutrase enzyme with
an IC50 value of 0.38 mg/mL. Five peptides were identified from this hydrolysate which were shown to possess
the ACE inhibitory activity: LQNIPPL (β-casein, residues
70–77), YQKFPQY (αs2-casein, residues 89–95), LPYP
YY (κ -casein, residues 56–61), SKVLPVPQK (β-casein,
residues 168–176), and FLPYPYY (κ–casein, residues55–
61). All these five peptides were identical with peptides
found in cow’s milk casein and possessed ACEinhibitory activities. Furthermore, for four out of the five
peptides, the C-terminus was occupied by a hydrophobic
amino acid, which is a characteristic feature of known
ACE inhibitory peptides (Jiang et al. 2007).
In a study by Mao et al. (2007a, 2007b), hydrolysates
obtained via Alcalase hydrolysis of yak milk casein were
shown to modulate the differentiation of T-helper cells
(Th) along with shifting the Th1/Th2 balance towards
Th1-dominant phenotype. Thus, it was suggested that
yak milk-derived hydrolysates could potentially help in
cell-mediated immune diseases (Mao et al. 2007a,
2007b). The Alcalase derived hydrolysates were also
found to suppress tumor cells (Mao et al. 2005). In another study, which tested the role of several different enzymes as well as different hydrolysis times in the
generation of bioactive hydrolysates, it was shown that
yak casein hydrolysates obtained from trypsin and
Alcalase hydrolysis yielded peptides with higher DPPHscavenging activities, as compared to flavozyme, papain,
and peptic hydrolysates. Furthermore, the 7 h long hydrolysis with Alcalase had the highest DPPH-scavenging
activity, compared to shorter hydrolysis periods (Mao et
al. 2011).
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Alcalase hydrolysis of the yak milk casein also led to
the generation of ACE inhibitory hydrolysates. The hydrolysate was further separated into different molecularsized fractions via membrane ultrafiltration. The highest
ACE inhibitory activity was shown by the 6 Da fractions
amongst all the other fractions of the hydrolysate. Two
novel peptides involved in the ACE inhibitory activity
were identified in the 6 Da fractions, which were, PLPLL
(β-casein, amino acid residues 136–140) and PPEIN (κcasein, amino acid residues 156–160). The IC50 and molecular weight of the two peptides were 566.4 and 550
Da, and 0.25 ± 0.01 and 0.29 ± 0.01 mg/mL, respectively
(Mao et al. 2007a, 2007b).
Alcalase derived yak casein hydrolysates have also been
shown to possess immunomodulatory and antioxidant activities, as the hydrolysates have been effective in reducing
the expressions of pro-inflammatory cytokines such as
tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL1β), and IL-6, as well as reducing free radicals of DPPH,
hydrogen peroxide, and superoxide (Wang et al. 2011).
However, the peptides in these hydrolysates have not been
separated and characterized. Moreover, Wang et al.
showed that yak casein hydrolysates were capable of mineral binding as they could bind ferrous and zinc ions to
form soluble complexes in simulated intestinal conditions
(Wang et al. 2011). The major binding sites consisted of
amide and carboxylate groups; however, specific peptides
have not been identified yet.
In a study by Pei et al. (2017), waste yak milk, produced as a by-product during production of yak butter,
was hydrolyzed by pepsin, and the hydrolysates produced were found to possess antimicrobial activity. On
further purification and analysis, two peptides were identified in the hydrolysate responsible for the antimicrobial
activity, namely, RVMFKWA and KVISMI. These peptides exhibited antimicrobial activities against bacteria
such as E. coli, Listeria innocua, Salmonella paratyphi,
and Enterobacter cloacae, as well as against certain fungi
(Pei et al. 2017).
Another recent study by Lin et al. (2018) highlights an
in silico proteolysis approach for the release of bioactive
peptides with ACE-inhibitory activity from yak milk casein, using single or combined enzymes. The study identified several peptides with ACE inhibitory properties such
as LPLPLL, KYIPIQ, and PFPGPIPN. Furthermore, their
cytotoxicity was also determined through ToxinPred (online toxin prediction tool), to find that the peptides identified were non-toxic (Lin et al. 2018). This study could
potentially serve as a guide for the actual yak milk protein
hydrolysis and the identification of bioactive peptides.
Mare

Mare’s (Equine) milk has been long used for its unique
therapeutic and nutritive values in the southern states of
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former Soviet Union and Mongolia, which is currently also
gaining acclamations in parts of Europe (Sheng and Fang
2009). Fermented mare milk, also known as Koumiss, has
been used as a curative for cardiovascular and digestive disorders in Mongolia and Russia (Lozovich 1995).
Some of the qualitative and quantitative characteristics
of mare milk which has been reported (Miranda et al.
2004; Uniacke-Lowe et al. 2010) are as follows:
 Mare milk contains about 2.7% of total proteins, out









of which 55% is casein, while the rest is composed
of β-lactoglobulin, α-lactalbumin, whey proteins,
immunoglobulins, and lysozyme.
Proteins in mare milk are rapidly hydrolyzed by
human gastrointestinal enzymes as compared to
other popular milk proteins such as cow, camel,
goat, and human milk proteins.
Casein fraction of mare milk is considerably made
up of β-casein, followed by αs1-casein, αs2-casein,
and κ-casein.
The αs1-casein in mare milk is composed of 205
amino acids with 6 phosphorylation sites, and 5 of
those sites are so close to each other that they are
considered as a probable source of bioactive
peptides.
The β-casein of mare milk consists of 226 amino
acids with 7 potential phosphorylation sites at the
C-terminal.

Although very limited research is available on the bioactive peptides released from mare milk, koumiss (fermented mare milk) has been reported to have ACE
inhibitory activity (IC50 52.5 ± 2.9 mg/mL). The ACE inhibitors found in koumiss are reported to be true inhibitors or the prodrug type inhibitors, based on the
hydrolysis pattern of the gastrointestinal enzymes (Chen
et al. 2010). The fraction with the highest ACEinhibitory activity (IC50 80.11 ± 2.13 mg/mL) was < 3 kDa
in molecular weight and 21 peptides were separated
from the fraction which showed variable ACE-inhibitory
activity. There were 4 most potent peptides identified
with ACE-inhibitory activity among 21 other peptides.
The only ACE-inhibitory peptide found in koumiss was
derived from the peptide P1 (β-casein, amino acids 217–
241) (Chen et al. 2010). Protein P2 originated from cytochrome c, whereas proteins P3 and P4 were of unknown
origin, probably of microbial origin. The unique feature
of P1 ACE-inhibitory peptide is its length, which is 27
amino acids residues long, but still possesses high ACEinhibitory activity. In general, such high activities are a
characteristic of smaller peptides (2–10 amino acid residues) (Ricci et al. 2010).
In another study by Kusumaningtyas et al. (2018), hydrolysis of the Sumbawa mare milk protein via Bacillus
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thuringenesis protease yielded hydrolysates capable of
exhibiting antibacterial and antioxidant activities. The
peptide fraction which was < 3 kDa in molecular size,
obtained from a 30 min hydrolysis, was shown to be
the most potent antibacterial fraction and more effective against Gram-negative bacteria. The peptide
identified was HPYFYAPELLYYANK (Kusumaningtyas
et al. 2018).
Donkey milk

The increasing interest of consumers and researchers towards donkey milk is due to its similarity to human milk
which paves the way for new avenues regarding its
utilization as a functional ingredient or consumption as
liquid food. It is reported to possess many health virtues
owing to its antimicrobial, anti-inflammatory, antibacterial and anti-carcinogenic properties (Martini et al. 2018).
Miao et al. (2020) had studied the effect of different processing conditions and fermentation characteristics of
donkey milk and concluded that a higher peptide content was obtained upon its fermentation with L.helveticus LZ-R-5 and L. helveticus. On the other hand,
digestion of donkey milk with pepsin and a mixture of
pancreatic enzymes yielded 46 peptides, among which
30 peptides were from β-casein fraction of the milk
(Bidasolo et al. 2012). They established the ACE inhibitory activity of the peptide (β-CN fragment f(176–185)
[VAPFPQPVVP]) with an IC50 of 48.8 ± 2.3 mM. Piovesana et al. (2015) performed peptidome characterization
of donkey milk and purified various peptides. Peptides
were then analyzed for their bioactivities which
showed35% antioxidant activity and 67% ACE inhibitory
activity. Another peptide, TKTEEGEFISEGGGVR, was
reported by the same authors, which was reportedly a fibrinopeptide, and had a role in haemostasis. In another
study by Aspri et al. (2018), fermented goat milk samples
were subjected to in vitro gastrointestinal digestion
followed by analysis of digesta for ACE inhibitory activity. The results revealed that Enterococcus faecum DM33
fermented milk yielded peptides from casein and whey
fractions which depicted the strongest antioxidant and
antimicrobial activities, while donkey milk fermented
with Lactobacillus casei DM214 revealed the highest
ACE inhibitory activity. Antioxidant and ACE inhibitory
activity exhibiting peptides were also isolated and purified from donkey milk by Zenezini Chiozzi et al. (2016),
which were, namely, EWFTFLKEAGQGAKDMWR,
GQGAKDMWR, and REWFTFLK, MPFLKSPIVPF respectively. Tidona et al. (2011) had evaluated the
in vitro digestibility of donkey milk with gastric pepsin
and duodenal juice containing various pancreatic enzymes. Digested samples exhibited significant antimicrobial activity against E. coli but not against B.
cereus. Furthermore, dose-dependent inhibition of
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Listeria monocytogens was also observed with digested
donkey’s milk (Table 3).
Bioactive peptides derived from milk products of minor
dairy species

Milk based products hold an important role in the daily
diet of people worldwide. Rearing of minor dairy species
for production of milk is limited; however different dairy
products are being manufactured to meet the local requirements. Fermentation based dairy products like
cheese, fermented milk, yoghurt are highly popular. The
data related to their preparation and physico-chemical
properties are widely available due to the rapidly increasing interest in these products. However, limited studies
have been carried out on bioactive properties of dairy
products obtained from minor dairy species (Table 4).
Cheese

The type and concentration of bioactive peptides in
cheeses may vary with thermal treatment of milk, type
of starter, manufacturing conditions, ripening stage, curd
scalding temperature, ripening stage, and rennet origin
(Kocak et al. 2020; Meira et al. 2012; Silva et al. 2006).
Among minor species, sheep and goat milk were widely
explored for preparation of different varieties of cheeses.
β-casein-hydrolyzed fragments f(201–204) (VRGP),
f(47–51) (DKIHP), and f(47–52) (DKIHPF), in 60 days
old Spanish goat milk cheese, possessed ACE inhibitory
activity (Gómez-Ruiz et al. 2006). In freeze-dried watersoluble extracts of sheep and goat milk cheese peptide,
sequences VPKVK, YQEP, and YQEPVLGP, from native
β-casein exhibited antioxidant and ACE inhibitory activity with higher extent of bioactivity in goat milk cheese
(Silva et al. 2006). In goat milk cheese, ethanol soluble
and insoluble nitrogen fractions showed ACE inhibitory
activity owing to the small and medium sized peptides.
Similarly, acid soluble and non-protein nitrogen fractions, consisting of medium and short chain peptides,
possessed antioxidant activity (Hernández-Galán et al.
2017). Water soluble extracts of goat milk-based Tulum
cheese, not only showed antioxidant activity and iron
chelating ability, but also exhibited antimicrobial activity
against Salmonella typhimurium ATCC 14028 on the
90th day of ripening (Öztürk and Akin 2018). The incorporation of adjunct cultures (Lactobacillus casei,
Lactobacillus plantarum and Lactobacillus bulgaricus)
with a starter mix (Lactococcus lactis subps lactis and
Lactococcus lactis subspcremoris), for the preparation of
goat milk brined cheese, contributed to the higher concentration of ACE inhibitory and antioxidant activity
peptides along with other water-soluble nitrogenous
compounds. These differences could be attributed to
strain-dependent peptidase activity of adjuncts. However, all the samples, irrespective of type of culture mix,

ND
ND
LHSMKEGNPAHQKQP (αs1-CN, f120–134)
PLRVYVEELKP (β-Lg, f 38–48) PEQSLACQCL
(β-Lg, f 113–122) SDIPNPIGSENSGKTTMPL
(αs1-CN, f 180–198)
SLTLTDVEKLHLPL (β-CN, f 124–137)
ND
ND
ND

ND
ND

ND
FHKFICKMMKIYL

Anti-oxidant activity

Anti-oxidant activity

Anti-oxidant activity

Anti-microbial activity

Anti-bacterial activity

Anti-fungal activity

ACE-inhibitory activity

Anti-bacterial peptides

ACE-inhibitory activity

Anti-microbial activity

IC50 4.45 μM (whey fraction)
4.27 μM (Casein fraction)

PEQSLACQCL (β-lg, residues 113–122)
QSLVYPFTGPI (β-CN, residues 56–66)
ARHPHPHLSFM (κ-CN, residues 96–106)

MHQPPQPL (β-CN, f144–151)
SPTVMFPPQSVL (β-CN, f152–163)
VMFPPQSVL (β-CN, f155–163)
INNQFLPYPY (κ-casein, f51–60)

(Ibrahim et al. 2017)

230.7 to 269.0 mg/mL

ND

DPP–IV inhibitroy activity
(Anti-diabetic activity)

(Espejo-Carpio et al. 2014)

88.91%

ND

(Tomazou et al. 2019)

(Espejo-Carpio et al. 2014)

IC50 value of 218.50 μg/ mL
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ND

(Osman et al. 2016)

(Shu et al. 2017)

(Luz et al. 2020)

(Lestari and Suyata 2019)

(Esmaeilpour et al. 2016)

(Ahmed et al. 2015)

Minimum inhibitory activity 0.09 and
0.03 mg/mL against Escherichia coli
and Bacillus cereus

71.04 ± 0.37% to 83.31 ± 0.45%

Minimum inhibitory activity
(3.9–62.5 g/L)
minimum fungicidal concentration
(15.8–250 g/L)

Highest Activity against E. coli
and S. aureus

Highest activity against E. coli
and B. cereus

ND

(Shu et al. 2018)
(De Gobba et al. 2014)

ABTS (SC50 4 μg/ mL) Iron
chelation activity IC50 65 μg/ mL

(Zhang et al. 2015)

ND

88.01 ± 0.69%

(Gong et al. 2020)

ND

(Chen et al. 2018)

(Geerlings et al. 2006)

IC50 316–354 μmol/L

TGPIPN (β-CN, f78–83)
SLPQ (β-CN, f84–87)
SQPK (β-CN, f181–184)

(Bao et al. 2016)
(Minervini et al. 2003)

ND

LVYPFPGP (β-CN, f58–65)
TVDQHQ (αS2-CN, f182–187)

Reference

95.31%

Activity

ND

Peptide Sequence

SDIPNPIGSE (αS1-casein, f195–204)
NPWDQVKR (αS2-casein, f123–130)
SLSSSEESITH (β-casein, f30–40)
QEPVLGPVRGPFP (β-casein, f207–219)

ACE-inhibitory activity

Goat

Anti-diabetic activity

Function

Species

Table 3 Bioactive peptides derived from milk of minor dairy species
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Camel Milk

Species

FLQY (αs2-CN, f71–74)
FQLGASPY (αs1-CN, f168–175,
ILDKEGIDY (α-La, f95–103),
ILELA (αs1-CN, f28–32),
LLQLEAIR (αs1-CN, f108–115),
LPVP (β-CN, f172–175),
LQALHQGQIV (αs2-CN, f75–84),
MPVQA (β-CN, f186–190)

DPP-IV inhibitory activity

ND

ACE-inhibitory activity

KFQWGY
SQDWSFY
YWYPPQ

ND

Anti-oxidant activity

Cholesterol esterase
inhibitory activity

ND

Anti-oxidant activity

ND

DLENLHLPLPL
LTDLENLHLPLPL
TDLENLHLPLP
TDLENLHLPLPL
TLTDLENLHLPLPL

ACE-inhibitory activity

KDLWDDFKGL
MPSKPPLL

LSLSQFKVLPVPQ (βCN, f178–191)
KVLPVPQQMVPYPQ (βCN, f185–198)
TDLENLHLPLPL (βCN, f144–155)

ACE-inhibitory activity

Anti-inflammatory activity

IYMESPQPTDTSPAQ (Lactophorin, f14)
FRNTATQSEETKE (Lactophorin, f14)
QMVPYPQR (βCN, f14)
IASEDGGKTDVMPQ (α-S1 CN, f14)
SSFRNTATQSEE (α-S1 CN, f14)

Anti-microbial activity

Anti-obesity

ATTLEGKLVEL (Lactophorin B, f79 to 89)
KADAVTLDGGL (Lactoferrin, f53 to 63)
KFGRGKPSGFQL (Lactoferrin, f277 to 288)

Anti-oxidant activity

ISQYYQK (αS2-CN, f182–189)
FAWPQYLK (αS2-CN, f189–197)

Anti-fungal activity
LEEQQQTEDEQQDQL (LL-15]
YLEELHRLNAGY (YY-11)
RGLHPVPQ (RQ-8)

VLPVPQKAVPQ,
VLPVPQKVVPQ
TQTPVVVPPFLQPEIMGVPKVKE

ACE-inhibitory activity

Anti-oxidant activity

Peptide Sequence

Function

Table 3 Bioactive peptides derived from milk of minor dairy species (Continued)

ID90 0.2 mg/mL

LPVP IC50
87.0
MPVQA IC50
93.3 μM

ND

ND

(Nongonierma et al. 2018)

(Mudgil et al. 2019)

(Mudgil et al. 2018)

(Abu-qatouseh 2019)

(Moslehishad et al. 2013)

(Jrad et al. 2014)

1.6 μmol TEAC/mg protein and 0.25 μmol
TEAC/μmol eq. NH2
2.223 to 3.930 mg/mL

(Kumar et al. 2016a, 2016b)

(Jrad et al. 2014)

(Alhaj 2017)

(Algboory and Muhialdin 2018)

(Ibrahim et al. 2018)

(Homayouni-Tabrizi et al. 2017)

(Zanutto-Elgui et al. 2019)

(Aslam et al. 2018)

Reference

91.28% inhibition; 32.25% DPPH radical
scavenging activity;

ND

Against Staphylococcus faecalis, Shigella
dysenteriae, Staphylococcus aureus and
E. coli.

ND

ND

Against Aspergillus oryzae and Aspergillus
flavipes

ND

Activity
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IC50 70.8 μM
IC50 71.2 μM

IIVTQTMK (β-LG, f 1–8)
IDALNENK (β-LG, f 84–91)

ACE-inhibitory

ACE-inhibitory

Mare

IC50 380 μM (highest activity)

YQKFPQY (αs2-CN, f 89–95), LQNIPPL
(β-CN, f 70–77), SKVLPVPQK (β-CN, f 168–176),
LPYPYY (κ-CN, f 56–61), FLPYPYY (κ-CN, f 55–61)

(Chen et al. 2010)

IC50 250 μM

PLPLL (β-CN, f 136–140)

IC50 14.53 μM

(Jiang et al. 2007)

IC50 290 μM

PPEIN (κ-CN, f 156–160)

(2021) 3:2

YQNPRLGPTGELDPATQPIVAVHNPVIV (β-CN, f
217–241)

(Rizzello et al. 2005)

(Gómez-Ruiz et al. 2008)
Active against gram-positive and
gram-negative bacterial species

Potent inhibitor of linoleic acid oxidation

IC50 62.6 μM

ALPMHIR (β-LG, f 142–148)

VMFPPQSVL
(β-CN, f 155–163) and
VVAPFPEV (αs1-CN, f 24–31)

IC50 82.4 μM

LLF (β-LG, f 103–105)

HPHPHLSF (κ-CN, f 98–105)

IC50 3.5 μM

LQKW (β-LG, f 58–61)

Anti-microbial

–

MAIPPK (Casein macropeptide, f106–111),
MAIPPKK (Casein macropeptide, f106–112)

Anti-oxidant

(Girardet et al. 2000)

IC50 28.9 μM

LPYPY (κ-CN, f 56–60)

(Papadimitriou et al. 2007)

(Manso and López-Fandiño 2003)

IC50 15.7 μM

IAK (κ-CN, f 22–24)

(Qian et al. 1995)

IC50 10 μM
IC50 14.3 μM

(BEG et al. 1985)

YIPIQY (κ-CN, f 25–30)

IC50 24.1 μM

VRYL (αs2-CN, f 205–208)

(Gómez-Ruiz et al. 2007)

(Wali et al. 2020)

(Tagliazucchi et al. 2016)

EKDERF (κ-CN, f 12–17)

IC50 2.6 μM

LKKISQ (αs2-CN, f 165–170)

ABTS assay
2.4, 1.8 and 0.9 mg/mL

IC50
DPPH assay
1.9, 1.2 and 0.6 mg/mL

IC50 ¼ > 1000 mmol/ L

IC50 2.4 μM

Anti-oxidant activity

(Rahimi et al. 2016)

IC50 73 μg/mL
(Soleymanzadeh et al. 2019)

(Shuangquan et al. 2008)

IC50 = 19.9 μmol/L

8933.05 mM TEAC/mg peptide ACE-I
IC50 = 30 mM

Reference

Activity

PYVRYL (αs2-CN, f 203–208)

VAHIPS (aS2-CN, f27–32)
RLDGQGRPRVWLGR (TFI-b1),
TPDNIDIWLGGIAEPQVKR (TFI-b2)
VAYSDDGENWTEYRDQGAVEGK
(TFI-b3)

ACE-inhibitory activity

ACE-inhibitory

ND
MVPYPQR (β-CN, f 193–199)

ACE-inhibitory activity

ACE-inhibitory activity

Anti-oxidant and
ACE-inhibitory activity

Peptide Sequence
Ala-Ile-Pro-Pro-Lys-Lys-Asn-Gln-Asp
(κ-CN, f107–115

Function

Yak

Sheep

Species

Table 3 Bioactive peptides derived from milk of minor dairy species (Continued)
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ND = Not defined

WFTFLKEAGQGAKDMWR
GQGAKDMWR
ND

Anti-microbial activity

ND

REWFTFLK
MPFLKSPIVPF

Anti-oxidant activity

ND

VAPFPQPVVP (β-CN, f176–185)

ACE-inhibitory activity

IC50 13.42 μM

Inhibitory activity against E.coli
and L. monocytogenes

ND

ND

NHRNRMMDHVH
LNVSSETVES (β-CN)
GENLRLPVHL (β-CN)
IQPFMHQVPQ (β-CN)
ENSEKTDIIP (αs1-CN)
MGSTEIFPEE (αs2-CN)
IELSDEEKNY (αs2-CN)
IPQTMQDLDL (β-Lg)
QEVAGKWHSV (β-Lg)
AMAASDISLL (β-Lg)
DSESAPLRVY (β-Lg)

IC50 5.19 μM

LLLALILL

Anti-oxidant activity and
ACE-inhibitory activity

IC50 9.82 μM

PKDLREN (CPN1, f 144–150)

Donkey milk

Activity

Peptide Sequence

Function

Species

Table 3 Bioactive peptides derived from milk of minor dairy species (Continued)

(Tidona et al. 2011)

(Zenezini Chiozzi et al. 2016)

(Bidasolo et al. 2012)

(Aspri et al. 2018)

Reference
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ACE-inhibitory

Arg-Pro-Lys-His-Pro-Ile-Lys-His-*

ND

DKIHP (β-CN f(47–51))
DKIHPF (β-CN f(47–52))

Goat milk Tulum cheese

Cabrales cheese (Cow + sheep + Goat milk)

Goat milk

Yoghurt

ND

ND

DPPH scavenging activity

Antibacterial

L.KKISQ.R (α-s2 f(165–169))

38.0 ± 1.0%

39.0 ± 1.0%

ND

(Sultan et al. 2017)

(Atanasova et al. 2020)

(Gómez-Ruiz et al. 2006)

113.1 μM
2419.4 μM

ND

(Öztürk and Akin 2018)

(Hernández-Galán et al. 2017)

(Kocak et al. 2020)

ND

ND

62.55%

(Meira et al. 2012)

(Silva et al. 2006)

References
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Yoghurt

Immunopeptide

RPKHPIKHQGLPQEVLNENL.L (α-s1 f(1–20))

Sheep milk cheese

ACE inhibitory

Antioxidant, Mineral binding and
antibacterial activity against
Salmonella typhimurium ATCC 14028

Antioxidant and ACE inhibitory

ACE inhibitory activity

White brined goat cheese

Manchego cheese (Sheep milk)

Idiazabal cheese (Sheep milk)

ND

Cerrillano

ND

67.71 ± 3.2 IC50 μg/mL
74.96 ± 1.6 IC50 μg/mL

HQPPQPLPPTVMFPPQSVL β-CN f(160–178)
YQEPVLGPVRGPFPI β-CN f(206–220)
QEPVLGPVRGPFPILV β-CN f(207–222)
QEPVLGPVRGPFPI β-CN f(207–220)
PVLGPVRGPFPI β-CN f(209–220)
LGPVRGPFPI β-CN f(211–220)
TDAPSFSDIPNPIGSENSGK αS1-CN f(189–208)
DIPNPIGSENSGKTTMPLW αS1-CN f(196–214)
IPNPIGSENSGKIT αS1-CN f(197–210)
NAGPFTPTVNR αS2-CN f(131–141)
YQGPIVLNPWDQVKR αS2-CN f(116–130)
YQGPIVLNPWDQVK αS2-CN f(116–129)
GPIVLNPWDQVKR αS2-CN f(118–130)
VLNPWDQVKR αS2-CN f(121–130)

Pecorino Sardo

Fresh goat milk cheese

87.46 ± 0.2 IC50 μg/mL

MHQPPQPLPPTVMFPPQSVL β-CN
f(159–178)

Roquefort

White brined goat milk cheese

67.21 ± 0.1 IC50 μg/mL

WMHQPPQPLPPTVMFPPQSVL β-CN
f(158–178)

Pecorino Toscano

32.71 ± 1.8 IC50 μg/mL

892.83 ± 0.11 IC50 μg/mL

689.40 ± 0.18 I IC50 μg/mL
0.072 ± 0.06 I IC50 μg/mL

169.86 ± 0.10 IC50 μg/mL
0.102 ± 0.10 IC50 μg/mL

93.75 ± 0.06 IC50 μg/mL
0.079 ± 0.15 IC50 μg/mL

Activity

Identified in Roquefort type cheese
KEMPFPKYPVE β-CN, f(122–132)

ACE inhibitory expressed as ABTS
(%) scavenging rate

ACE-inhibitory Antioxidant activity

ACE-inhibitory Antioxidant activity

Tyr-Gln-Glu-Pro
Tyr-Gln-Glu-Pro

ACE-inhibitory Antioxidant activity

Function

Val-Pro-Lys-Val-Lys

Peptide

Feta

Sheep Milk cheese

Goat milk cheese-like system

Sheep milk cheese-like system

Cheese

Product

Table 4 Bioactive peptides derived from milk products of minor dairy species

Guha et al. Food Production, Processing and Nutrition
Page 14 of 21

YPVEPFTE (β-CN f(114–121))

Greek sheep milk yoghurt

Function

Dipeptidyl peptidase IV
inhibitor
Anti-thrombotic

AASDISLLDAQSAPLR (β-lg f(43–58))
INNQFLPYPY (κ-CN f(42–51))
TAQVTSTEV (κ-CN f(154–162))

Goat milk Kefir

ND = Not defined

Anti-bacterial

ND

Antioxidant activity

ND

Goat milk Kefir

ACE inhibitory

ACE inhibitory and Opiate like activity

Antihypertensive

ACE inhibitory

Antioxidant
Antimicrobial against L. monocytogenes 1078

Antioxidant activity against TCDD (dioxin)

Anti-hypertensive

Antimicrobial activity against
Staphylococcus aureus and E. coli

Reducing power (%)
DPPH (% inhibition)

DPPH activity
ABTS activity

ACE inhibitory
Antimicrobial activity

Antioxidant activity

Goat milk Kefir

Kefir and Koumiss

ND
PVVVPPFLQ (β-CN f(96–104))

Fermented mare milk

ND

Donkey milk fermented with Enterococcus faecium DM33

Sheep milk yoghurt

AHTPDB

Total 32 peptides

Fermented camel milk

Casein fractions

ND

Camel milk heated at 80 °C/30 min prior to fermentation

Goat milk yoghurt

ND

Fermented camel milk (Chal)

Goat milk yoghurt

ND

ND

ND

Peptide

Fermented camel milk yoghurt

Sheep milk

Product

Table 4 Bioactive peptides derived from milk products of minor dairy species (Continued)

ND

ND

ND

ND

75%

ND

ND

70.9–74.5%

350 ± 0.01

ND

ND

20.0 and 16.0%, respectively

(Izquierdo-González et al. 2019)

(Satir and Guzel-Seydim 2015)

(Shi et al. 2018)

(Papadimitriou et al. 2007)

(Dalziel et al. 2018)

(Wang et al. 2015)

(Aspri et al. 2018)

(Haskito et al. 2020)

(Parmar et al. 2020)

(Algboory and Muhialdin 2018)

(Abd Elhamid and Mervet 2017

(Soleymanzadeh et al. 2016)

57.90 ± 4.59 μM
1484.35 μM
16.93%
22.70%

(Alhaj et al. 2018)

References

113–200
70–133

40.0 ± 1.4%

40.3 ± 1.1%

Activity
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showed a similar peptide profile. ACE inhibitory activity
increased during ripening to a certain level and decreased thereafter due to breakdown of responsible peptides to lower molecular weight fragments (Kocak et al.
2020).
A water-soluble peptide extract of Pecorino Romano
cheese, made from sheep milk, was found to be potentially active against certain pathogenic bacteria such as
Bacillus megaterium, E. coli, Yersinia enterocolitica,
Lactobacillus innocua, Staphylococcus aureus, and Salmonella spp with minimum inhibitory doses ranging
from 20 to 75 μg/mL (Rizzello et al. 2005).
Water soluble extracts of different market samples of
feta, Roquefort, Pecorino Sardo-Cerrillano, and Pecorino
cheese of sheep’s milk possessed prominent antioxidant
and ACE inhibitory activities. However, water soluble
extracts of Roquefort-type displayed the best antihypertensive and antioxidative properties due to its complex
peptide profile. Total nine peptides from β-casein fraction, five peptides from αs2-casein and three from αs1-casein were identified having antioxidant and ACE
inhibitory peptides sequence homology identified in
other cheeses. All the bioactive peptides had at least one
proline amino acid residue which had been reported to
contribute to ACE inhibitory and antioxidant activity
(Meira et al. 2012). Sheep milk-based probiotic, Scamorza cheese, showed the potential of yielding bioactive
peptides. Probiotic cultures (Bifidobacterium longum
BL-46 and Bifidobacterium lactis BB-12) liberated higher
amount of low molecular peptides during secondary proteolysis as compared to control cheese. The β-casein
f(210–220), αs1-casein f(1–23), κ-casein f(78–90) and
αs1-casein f(1–6) protein fragments were observed in
Scamorza cheese (Albenzio et al. 2015). Atanasova et al.
(2020) identified 31 and 22 bioactive peptides in sheep
and goat milk-based white brined cheese of Bulgarian
origin, respectively. Peptides were majorly obtained from
hydrolysis of αs1-casein, αs2-casein and β-casein. The
identified peptides were having ACE inhibitory, αs1-casokinins, caseinophosphopeptide and immune peptide activity (Table 4).
Fermented milk (yoghurt)

Bioactivities of fermented milk increase during initial
storage period due to the active metabolism of the
starter, followed by a decrease after a certain interval
due to modification and degradation of the bioactive
fractions (Sultan et al. 2017). Bioactive peptides derived
from Lactobacillus acidophilus and Streptococcus thermophilus fermented camel milk showed ACE inhibitory
and antimicrobial activities against Bacillus cereus, Salmonella Typhimurium, and Staphylococcus aureus. Bioactivities were time and strain-dependent wherein
microbial inhibition activity was observed after 12 h of
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incubation till 15 days (Alhaj et al. 2018). Camel milk
fermented by Leuconostoc lactis, isolated from traditional
fermented camel milk (Chal),had antioxidant activity as
revealed by significantly higher ABTS and DPPH activity
(Soleymanzadeh et al. 2016). Antioxidant potential of
camel milk increased after fermentation. Reducing power
assay and percentage DPPH inhibition of yoghurt prepared from camel milk increased significantly (p < 0.01)
on heating the camel milk at 80 °C for 30 to 120 min. On
heating, protein unfolding and exposure of thiol groups
acts as hydrogen donor while on severe heating, prooxidants get consumed during Maillard reaction, producing melanoidin with strong antioxidant activity. However,
percentage inhibition decreased during cold storage of
yoghurt. The bioactive peptides in yoghurt possessed antimicrobial potential against B. cereus, E. coli, and S. aureus
(Elhamid & Mervet, 2017). Camel milk fermented with
Lactobacillus plantarum had 32 peptides belonging to lactophorin (6), αs2-casein (7), β-casein (9), αs1-casein (10)
proteins and showed antimicrobial activity against Grampositive and Gram-negative bacteria including S. aureus,
E. coli, Shigella dysenteriae, and Staphylococcus faecalis
(Algboory and Muhialdin 2018).
Casein derived bioactive peptides from goat milk yoghurt reduced the renal and aorta malondialdehyde in deoxycorticosterone hypertensive rats (Padaga and Sujuti
2015). Goat (Beetal breed) and sheep (Kajli breed) yoghurt prepared using Streptococcus thermophilus and
Lactobacillus bulgaricus showed anti-hypertensive and
antioxidative potential. Peptide concentrations in goat
and sheep yoghurt were 6.50 mg/mL and 5.13 mg/mL,
respectively, which increased during storage because of
enzymatic proteolysis (Sultan et al. 2017). Three different 16 amino acids containing bioactive peptides in goat
milk yoghurt from β-casein (LYQEPVLGPVRGPFPI,
YQEPVLGPVRGPFPIL, and VQSWMHQPPQPLSPT)
had antioxidant potential and protected rats from hypercholesterolemia (Mahdi et al. 2018). Goat milk fermented with five different Lactobacillus cultures showed
different concentrations of antihypertensive and Xpropyl-dipeptidyl aminopeptidase activity due to modification in their proteolysis level (Parmar et al. 2020).
Goat milk yoghurt prevented 2,3,7,8-tetrachlorodibenzo-p-diozin induced lung damage in male rats due
to antioxidant activity of yoghurt casein (Haskito et al.
2020). Sheep milk based Greek yoghurt prepared with
standard yoghurt culture and Lactobacillus paracasei
subsp. paracasei DC412 possessed higher content of bioactive peptides in comparison to standard yoghurt
culture-based product. Most of the peptides were derivative of casein and the fragment 114–121(YPVEPFTE)
had ACE inhibitory and opioid like activity. However,
the peptide content and anti-hypertensive properties of
water-soluble extracts of Greek yoghurt increased during
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storage (Papadimitriou et al. 2007). Sheep milk yoghurt
led to faster colonic transit in rats due to absence of βcasomorphin precursor as it promotes the feeling of satiety and calms down any colonic over-activity. Several
identified bioactive peptides in sheep yoghurt included
αs1-casein f25–32 (VVAPFPEVF) with ACE inhibitory
properties, αs1-casein f180–193 (SDIPNPIGSENSGK)
with anti-microbial activity, β-casein 1f66–175 (SQPK
VLPVPQ) and β-casein 183–190 (RDMPIQAF) with
antioxidant potential, β-casein 192–209 (LYQEPVLGPV
RGPFPILV) with immunomodulation properties, and βcasein 193–207 (YQEPVLGPVRGPFPI) as an antimicrobial (Dalziel et al. 2018). Nguyen et al. (2020) reported
that lower peptide release in sheep milk yoghurt during
the early phase of gastric digestion was due to the dense
network and higher gel firmness as compared to goat
yoghurt. Dense gel network and cross-linked structures
hinder the accessibility of enzyme to cleave protein,
thereby slowing the peptide release. Both sheep and goat
yoghurts contained a higher number of identified peptides as compared to their corresponding milk. The βcasein f(96–104) (PVVVPPFLQ) showed antihypertensive activity in goat and sheep milk yoghurt.
Donkey milk fermented with different Lactobacillus
isolates exhibited antioxidative, antihypertensive, and
antimicrobial properties. The coupled action of fermentation and in vitro simulated gastrointestinal digestion
further enhanced the rich pool of bioactive peptides
available in donkey milk. The highest numbers of peptides were derived from β-caseinand β-lactoglobulin, as
their structures were more accessible to hydrolyzing enzymes (Aspri et al. 2018). Mare milk yoghurt possessed
lower ACE inhibitory activity as compared to cow and
soy milk due to absence of ACE-inhibitory tripeptides
IPP and VPP in mare milk (Wang et al. 2015).
Kefir and koumiss

Kefir is a naturally carbonated fermented milk product
produced using Kefir grains. Kefir grains consist of complex microflora which is responsible for the antihypertensive, antibacterial, and anti-inflammatory properties
of Kefir (Biadała et al. 2020). Kefir grains from different
regions of China revealed 3% inoculum of K1 grains at
25 °C for 22 h for the best production of goat milk-based
kefir. K1 kefir grains also outperformed kefir grains from
other locations in terms of ACE inhibitory and antioxidant activity (Shi et al. 2018). Goat milk of two different
breeds, Hair and Saanen, showed significant increase in
their antioxidant activity after being fermented with 2%
natural Kefir grains (Satir and Guzel-Seydim 2015). Goat
milk fermented with different strains of kefir grain
namely Lactobacillus kefiranofaciens subsp. KefirgranumDSM 10,550, Lactobacillus kefiri PCM 2501, Lactobacillus parakefiri DSM 10551, Lactobacillus brevis
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PCM 488, Lactobacillus delbrueckii subsp. lactis PCM
2611 showed antimicrobial activity against E. coli,
Salmonella, Micrococcus luteus and Proteus mirabilis
(Biadała et al. 2020). Different bioactivities of kefir were
reported in literature, however, identification and
characterization of such peptides is limited. IzquierdoGonzález et al. (2019) profiled the bioactive peptides in
goat milk kefir after 12, 24 and 36 h of fermentation
using peptidomics approach. In total, 11 bioactive peptides (Table 4) were identified after different fermentation time; however, maximum concentration was
obtained after 24 h which decreased thereafter. The
number of peptides was almost similar to control after
12 h fermentation as kefir was not mature and the proteolysis was low.

Future trends

The ability to generate bioactive peptides by food commodities is considered an important parameter owing to
their functional and nutritional properties. Proteins from
cow milk have been studied extensively as sources of
bioactive peptides. On the other hand, minor milk proteins and their related products have always been considered as the “dark” areas of research because of their
low economic significance. However, in recent years this
trend has been changing, as there is an increase in demand in finding alternative milk sources and milk products, particularly for their bioactive peptides. Various
bioactive peptides, derived from different milk protein
sources other than cow milk, have already shown diverse
biological activities such as ACE-inhibitory, metalbinding, antioxidant, antimicrobial activities among
many more, which have revealed unique peptides. However, there still exists a huge gap in knowledge in terms
of stability, bioavailability, and efficiency of these peptides, particularly in in vivo experiments and clinical trials, which paves a huge path for understanding the role
of these peptides in human health. A better understanding of these minor milk protein-derived peptides would
also aid the commercialization of the peptides for dietary
uses. This could be done by the following approaches:
 The use of recombinant enzymes and specific

microbial fermentations, such as use of special
coagulating enzymes during cheese fermentations,
could be a useful technique to give rise to novel
peptides from different milk and their associated
products.
 Understanding the structure-function relationship of
the peptides for a better insight into the biochemical
functions and their dietary implications using
powerful tools, such as cell culture, −omics, imaging,
and gut microbiome research.
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 Examining the toxicity, allergenicity, and stability of
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the peptides during gastrointestinal digestion of the
formulations after incorporating the bioactive
peptides into them.
Thus, minor milk protein-derived bioactive peptides
hold an enormous potential in the development of
nutraceuticals and functional foods which could be used
as a health ingredient. Also, characterization of bioactive
peptides derived from minor milk species would help in
their popularity and recognition across the globe.

Conclusion
The research on milk and milk products from minor
dairy species have been less promoted due to lesser animal
population with corresponding limited significance in the
economy. The availability of minor dairy animal’s milk
and milk products is also limited to local and regional
areas. However, the growing interest of consumers towards authentic traditional foods and substitute of bovine
milk with multifunctional properties, has lightened them
globally. Bioactive peptides liberated from bovine milk
proteins have been reported to possess various activities,
such as, antihypertensive, antioxidative, antimicrobial,
mineral binding, and immunomodulatory, etc. which represent its health and nutritional importance. However,
more sophisticated and long-term animal and human
studies are needed to validate these health benefits. Although rational information on bioactive peptides from
goat and sheep milk proteins is available now, limited research has been done on bioactive peptides from other
minor dairy animal’s milk and milk products. Identification, characterization and application of bioactive peptides
requires more attention of scientific community which
would be helpful in commercial application of milk protein derived bioactive peptides from milk and milk products of minor dairy animals to improve human health.
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